Publication Date:
2018-06-20
Description:
Metformin sensitizes endometrial cancer cells to chemotherapy through IDH1-induced Nrf2 expression via an epigenetic mechanism Metformin sensitizes endometrial cancer cells to chemotherapy through IDH1-induced Nrf2 expression via an epigenetic mechanism, Published online: 19 June 2018; doi:10.1038/s41388-018-0360-7 Metformin sensitizes endometrial cancer cells to chemotherapy through IDH1-induced Nrf2 expression via an epigenetic mechanism
Print ISSN:
0950-9232
Topics:
Medicine
Permalink